Generic Liraglutide prescription available online

Generic Victoza® is the first generic liraglutide and also the first generic GLP-1 product to come to the U.S. marketplace. It is indicated for: 

• Blood sugar control: Along with diet and exercise, Generic Victoza® is used to lower blood sugar (glucose) in adults and children who are 10 years of age and older with type 2 diabetes mellitus. 

• Cardiovascular benefits: Generic Victoza® is used to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes mellitus with known heart disease.  

Note: Generic Victoza® is not a weight-loss product, but it may help adults lose some weight. 

Like any GLP-1 receptor agonist, generic Liraglutide is not for use in people with type 1 diabetes. It should not be used with other medicines that contain liraglutide.  

As with other brand-name liraglutide medicines, generic liraglutide is most effective when used in combination with healthy lifestyle changes, including a healthy fitness plan and diet. 

Individual responses may vary. Generic liraglutide is available only by prescription. 

We are committed to delivering personalized solutions for our patients. Therefore, while we recognize generic Liraglutide as an outstanding option for many people, we want to suggest alternative choices to ensure you can access the most fitting treatments. Our doctors may recommend or prescribe various GLP-1 options depending on availability and individual preferences.  

•  Victoza® (brand-name liraglutide): Victoza® is an injectable prescription medicine used to treat people with type 2 diabetes (now available in the generic form). 

• Saxenda® (brand-name liraglutide): Saxenda® is a once-a-day injection that is FDA-approved for weight loss. Though Victoza and Saxenda have the same active ingredient, Saxenda has a maximum dose of 3 mg once a day whereas Victoza's maximum dose is 1.8 mg once a day. 

• Ozempic® (semaglutide): Ozempic® comes in a once-weekly injectable format, ensuring reliable blood sugar management and offering the added advantage of reducing cardiovascular risk.  

• Wegovy® (semaglutide): Wegovy® is an injectable prescription for weight loss and protection against life-threatening cardiovascular events. 

• Compounded Semaglutide (the active ingredient in Ozempic® and Wegovy®): Due to limited Ozempic® and Wegovy® supply, our doctors may prescribe compounded semaglutide, the active ingredient in Ozempic® and Wegovy®), in specific states, as long as Ozempic® remains on the FDA shortage list. It works similarly to branded Ozempic® and Wegovy®. Instead of it being packaged in an autoinjector pen, it will be delivered in a vial with syringes. *  

• Rybelsus® (semaglutide): This oral GLP-1 medication is FDA approved only for type 2 diabetes and introduces a convenient option for those favoring a pill over injections, ensuring effective regulation of blood sugar levels.  

•  Mounjaro® (tirzepatide): As a dual-action GLP-1 and GIP receptor agonist, Mounjaro® stands out, offering a comprehensive strategy for managing diabetes and effectively regulating blood sugar levels.  

• Trulicity® (dulaglutide): Trulicity® features a pre-filled, disposable pen, providing a convenient and once-weekly injection method for consistent blood sugar control.  

•  Bydureon® (exenatide): Bydureon®'s has the same active ingredient as Byetta, except that Bydureon is the longer acting version and the dosing is different between the two. Byetta was the first GLP-1 agonist medication FDA approved in 2005 and is a twice a day subcutaneous injection. Bydureon, on the other hand, is a once a week injection.  

*Prescriptions for compounded semaglutide are currently restricted to residents in the following states: AZ, CA, CO, DE, FL, GA, HI, IA, ID, IL, KS, MA, MD, ME, MO, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SD, TN, TX, UT, VA, WA, WV, Washington D.C., WY. It is important to note that compounded semaglutide is only available as an alternative to branded Ozempic® and Wegovy® as long as they remain on the FDA drug shortages list. If those branded medications are no longer on the FDA shortage list, compounded semaglutide will no longer be available. Although compounded semaglutide is not FDA-approved, our preferred pharmacy provider complies with pertinent federal and state laws and FDA regulations. Learn more about our controlled substances policy. 

Before using liraglutide injection, tell your healthcare provider if you have any other medical conditions, including if you: 

• have or have had problems with your pancreas, kidneys, or liver. 

• have severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems with digesting food. 

• are pregnant or plan to become pregnant. It is not known if liraglutide injection will harm your unborn baby. Tell your healthcare provider if you become pregnant while using liraglutide injection. 

• are breastfeeding or plan to breastfeed. It is not known if liraglutide injection passes into your breast milk. You should talk with your healthcare provider about the best way to feed your baby while using liraglutide injection.